The American Telemedicine Association has formed the Government Relations Special Interest Group to further the organization’s efforts to increase access to affordable virtual health.
Within the first few weeks of the COVID-19 pandemic the health care industry was rocked by a telehealth explosion of Big Bang proportions. In just the first few weeks of 2020, virtual health visits experienced a decade of anticipated growth, according to Kyle Zebley, VP of public policy at the American Telemedicine Association (ATA).
This impact, however, was not destructive, in Zebley’s view, but rather the “silver lining” of the pandemic. Lockdowns and fear...
Medtech companies require expertise to navigate complex AI regulations and integrate AI in medical software while addressing regulatory challenges, claims expert AI consultant with medtech experience.
The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.
Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.
The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.
The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.
Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.
The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.
